OVARY CANCER
Clinical trials for OVARY CANCER explained in plain language.
Never miss a new study
Get alerted when new OVARY CANCER trials appear
Sign up with your email to follow new studies for OVARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new type of CAR T cell therapy for adults with advanced solid tumors (like colorectal, lung, or pancreatic cancer) that have lost a specific marker on their cells. The treatment uses the patient's own immune cells, modified to target cancer cells while protecti…
Matched conditions: OVARY CANCER
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug combo targets Hard-to-Treat ovarian cancer
Disease control Recruiting nowThis study tests whether combining two drugs, senaparib and temozolomide, can shrink tumors in people with a certain type of ovarian cancer linked to an ARID1A gene change. About 18 adults with recurrent or persistent clear cell or endometrioid ovarian, fallopian tube, or primary…
Matched conditions: OVARY CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New drug combo aims to keep ovarian cancer at bay
Disease control Recruiting nowThis study is testing whether a combination of two drugs, mirvetuximab soravtansine and olaparib, can help keep recurrent ovarian, peritoneal, or fallopian tube cancer from growing back after initial treatment. The trial involves 53 women whose cancer has returned but still respo…
Matched conditions: OVARY CANCER
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
Supercharged immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a treatment where a patient's own immune cells are modified in a lab to better recognize and attack cancer cells that have a marker called NY-ESO-1. The study includes people with advanced cancers like sarcoma, melanoma, breast, lung, bladder, and ova…
Matched conditions: OVARY CANCER
Phase: PHASE1, PHASE2 • Sponsor: Hadassah Medical Organization • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Cherry juice may shield cancer patients from chemo nerve pain
Prevention Recruiting nowThis study tests whether drinking tart cherry juice can help prevent nerve damage (neuropathy) caused by the chemotherapy drug paclitaxel in people with breast or ovarian cancer. About 86 participants will be randomly assigned to take either a high or low dose of the juice daily …
Matched conditions: OVARY CANCER
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Prevention
Last updated May 17, 2026 00:59 UTC
-
Fasting during chemo: a new way to ease side effects?
Symptom relief Recruiting nowThis study looks at whether fasting every other day can reduce the harsh side effects of chemotherapy and improve quality of life for women with ovarian, endometrial, or uterine cancer. About 30 women who have had surgery and are about to start chemotherapy will either follow an …
Matched conditions: OVARY CANCER
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 17, 2026 01:00 UTC
-
Videos may boost genetic testing rates in ovarian and endometrial cancer
Knowledge-focused Recruiting nowThis study looks at whether showing educational videos about genetic testing helps more people with ovarian or endometrial cancer get tested. About 30 participants will watch a short video and may fill out a satisfaction survey. Researchers will compare testing rates before and a…
Matched conditions: OVARY CANCER
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 00:59 UTC
-
Ovarian cancer study aims for zero stomas
Knowledge-focused Recruiting nowThis study looks at whether it is safe to avoid creating a stoma (a surgical opening in the belly) after removing part of the bowel during ovarian cancer surgery. About 395 women with advanced ovarian cancer who are at low risk for complications will be followed. The goal is to s…
Matched conditions: OVARY CANCER
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC